CV Sciences (CVSI) Non-Current Deferred Tax Liability (2013 - 2026)
CV Sciences (CVSI) posted Non-Current Deferred Tax Liability of $7000.0 for Q1 2026, little changed sequentially from $7000.0 in Q4 2025, and up 75.0% YoY from $4000.0 in Q1 2025.
CV Sciences (CVSI) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends
CV Sciences has reported Non-Current Deferred Tax Liability for 13 years, with the latest figure at $7000.0 in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability rose 75.0% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7000.0 (up 75.0% YoY) and the FY2025 annual result came in at $7000.0, down 83.33% from the prior year.
- Non-Current Deferred Tax Liability was little changed at $7000.0 in Q1 2026 per CVSI's latest filing, from $7000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $240000.0 in Q4 2022 and troughed at $4000.0 in Q1 2025.
- A 5-year average of $42705.9 and a median of $19000.0 in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability surged 287.1% in 2022, then slumped 83.33% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $240000.0 in 2022, then sank by 40.83% to $142000.0 in 2023, then slumped by 70.42% to $42000.0 in 2024, then plunged by 83.33% to $7000.0 in 2025, then changed by 0.0% to $7000.0 in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $7000.0, $7000.0, and $4000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 42,000.00 |
| Dec 31, 2024 | 42,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |